Clinical Trials

The purpose of this study is to evaluate the effects of methylnaltrexone  on movement of solids through the digestive tract in healthy human subjects.

The purpose of this study is to understand the day-to-day variability in stomach emptying and gastrointestinal (GI) transit in patients with digestive symptoms. This information will be useful for interpreting the results of stomach emptying studies in future.

The purpose of this study is to evaluate the effects of A3309 on gastric, intestinal and colon transit in patients who have functional constipation.

The purpose of this study is to evaluate gastric, small-bowel, and colonic transit in subjects with IBS-C and IBS-D treated with multiple (three times daily) doses of olorinab (50 mg).

The purpose of this study is to evaluate the dose-dependent effects of TAK-954 on gastric emptying time of solids in participants with diabetic or idiopathic gastroparesis assessed by scintigraphy.